课题基金 / 基金详情

Novel Antiretroviral Agents

Novel Antiretroviral Agents
新型抗逆转录病毒药物
批准号:
6937859
负责人:
Bradford J Pistorio
金额:
$3.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-05-01 至 2006-01-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aim of the research is to develop molecules that induce apoptosis of HIV-infected cells. Viral replication of cells has been shown to occur through the formation of the amino acid hypusine by DOHH. The eukaryotic initiation factor 5A (elFSA) is the only protein to contain hypusine. Hypotheses suggest that when activated, elFSA can then stimulate ribosome function, stabilize mRNA, and transport HIV-mRNAs. A systematic approach toward synthesizing novel hypusine inhibitors will be performed to understand the SAR between the inhibitor and DOHH. Because deferiprone and ciclopirox have demonstrated inhibition of DOHH at high concentrations, the goal is to develop more effective pyridinone analogues. A class of HPOs will be synthesized, bearing substituents in the 2 and 5 position on the six-member ring. Acylation of the hydroxyl moiety will also be performed to prepare analogues as prodrugs to increase cellular permeability. Moreover, iron(lll) model compounds that are ideally similar to the octahedral metalloenzyme will be acquired to understand the bonding nature between the chelator and iron(lll). Finally, HIV-infected H9 cells will be treated with newly designed molecules, and the apoptotic behavior of these cells will be inspected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
TLS聚合酶Polη乙酰化修饰的动态调控和功能研究